Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.2600
+0.0150 (6.12%)
Dec 19, 2025, 2:51 PM EST - Market open
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $9.29 million as of December 19, 2025. Its market cap has decreased by -70.91% in one year.
Market Cap
9.29M
Enterprise Value
8.49M
1-Year Change
-70.91%
Ranking
Category
Stock Price
$0.26
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $9.29M, a decrease of -96.81%. That is a compound annual growth rate of -28.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 8.76M | -72.89% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | 71.18M | 93.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |